In the mice model, when the exonuclease domain of Pol δ (encoded by the POLD1 gene) or Pol ɛ (encoded by the POLE gene) was inactivated by mutation at exonuclease, catalytic residue elevated base substitution mutation rates, and increased incidence of cancers was observed. Here, POLE is linked to cancer.